Drugging the Elusive KRAS

Поделиться
HTML-код
  • Опубликовано: 7 сен 2022
  • Kevan M. Shokat, PhD, shifted the paradigm of targeted cancer therapy by drugging an “undruggable” protein and paving the way for future advances. AACR.org/Stories

Комментарии •